Postoperative multimodal analgesia
Conditions
Interventions
LB1(199mgLB):Bupivacaine liposome 15ml+0.9% Nacl 5ml
LB2(133mgLB):Bupivacaine liposome 10ml+0.9% Nacl 10ml.
LB3(67mgLB):Bupivacaine liposome 5ml+0.9% Nacl 15ml.
Sponsors
Chongzhou City Maternal and Child Health Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: ? Cesarean section; ?ASA is classified as Grade I or II; ? The medical history data is comprehensive and reliable; ? Patients can cooperate with effective communication.
Exclusion criteria
Exclusion criteria: ? There are serious central or peripheral nervous system diseases, cardiovascular system diseases and liver and kidney diseases; ? Abnormal coagulation function, infection at puncture site and spinal deformity; ? There is a history of opioid allergy; ? There is a history of drug abuse or dependence; ? There are contraindications for spinal anesthesia; ? There are serious obstetric complications; ? There is a history of chronic pain; 8 bradycardia and ? degree atrioventricular block.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of postoperative analgesia in each group; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative pain;Sedation score;Application of analgesic drugs;Muscle strength grading;Patient satisfaction;Incidence rate of adverse events;Postoperative lactation;The existence of postoperative block plane;Neonatal neurobehavioral measurement;Postoperative exhaust time;Indwelling time of urinary catheter;LOS; | — |
Countries
China
Contacts
Public ContactChen Lan
Chongzhou city Maternal and Child Health Hospital
Outcome results
None listed